F.D.A. advisers voted that the benefits of a nonprescription pill outweigh the risks. If the agency decides to move on the recommendation, the progestin-only contraceptive could be in stores within a few months.
Author: ALISHA HARIDASANI GUPTA
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}